Advancing Tricuspid Valve Replacement: Real-World Outcomes and Best Practices
'Advancing Mitral & Tricuspid Valve Interventions: Translating Evidence and Real-World Data into Clinical Practice' is a new educational webinar series designed to deliver evidence-based education on transcatheter tricuspid and mitral valve therapies (TMTT). The programme highlights emerging clinical data, evolving guideline recommendations, and practical insights from leading international experts to support optimal patient-centred management.
The first webinar in this series, Advancing Tricuspid Valve Replacement: Real-World Outcomes and Best Practices, will focus on Transcatheter Tricuspid Valve Replacement (TTVR). This session will review the latest registry data, pivotal clinical trial results, and real-world evidence, translating new findings into clinical practice through an interactive, case-based discussion.
An expert faculty panel - Dr Raj Makkar (Cedars-Sinai Medical Center, Los Angeles, US), Dr Rebecca Hahn (Columbia University Medical Center, New York, US), Dr Fabien Praz (Bern University Hospital, Bern, CH) and Dr Rahul Sharma (Stanford University, Palo Alto, US) will work toward expert consensus on best-practice approaches for patient selection and management of tricuspid regurgitation (TR).
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and Radcliffe Medical Education. PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.
PeerPoint Medical Education Institute designates the live format for this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Learning Objectives
- List clinical trial data and real-world evidence for TTVR
- Recall guideline recommendations for TTVR
- Select appropriate patients for TTVR based on the heart-team and patient choice
- Use expert guidance to develop an evidence-based approach to managing TR with TTVR
Target Audience
- Interventional Cardiologists
- Echocardiographers
- Cardiac Surgeons
- Other Allied HCPs
More from this programme
Part 1
Introduction
| 1 session | |
| Introduction | Watch now |
Part 2
Evolving Evidence in TTVR
| 1 session | |
| Evolving Evidence in TTVR | Watch now |
Part 3
Guideline Recommendations for TTVR
| 1 session | |
| Guideline Recommendations for TTVR | Watch now |
Part 4
Case Presentation
| 1 session | |
| Case Presentation | Watch now |
Part 5
Panel Discussion and Audience Q&A
| 1 session | |
| Panel Discussion and Audience Q&A | Watch now |
Faculty Biographies
Raj Makkar
Interventional Cardiologist
Dr Raj Makkar is a world-renowned leading expert in interventional cardiology and is one of the most widely cited researchers on the management of valvular heart disease. He has performed the greatest number of transcatheter valve implantation (TAVI) procedures in the world and has led the field in advancing the procedure to ensure the best outcomes for patients. In 2020, he performed the most transcatheter mitral valve repair procedures with the MitraClip system in the United States and is the national principal investigator for mitral valve replacement research studies.
His research interests focus on novel transcatheter therapies to treat structural heart disease, with a focus on studies that directly demonstrate improvements in patient outcomes. Since 2010, he has been the Stephen R. Corday Chair in Interventional Cardiology at Cedars-Sinai Heart Institute, Los Angeles, and has led the clinical program and trained over 50 fellows…